Eosinophilic peritonitis induced by sucroferric oxyhydroxide. Issue 4 (July 2020)

• Record Type: Journal Article
• Authors: Minato, Saori; Miyazawa, Haruhisa; Kitano, Taisuke; Shindo, Mitsutoshi; Ito, Kiyonori; Ueda, Yuichiro; Hirai, Keiji; Hoshino, Taro; Ookawara, Susumu; Morishita, Yoshiyuki
• Is Part Of: Peritoneal dialysis international. Volume 40:Issue 4(2020)
• Page Start: 419
• Page End: 421
• Publication Date: 2020-07
• Subjects: Eosinophilic peritonitis -- peritoneal dialysis -- sucroferric oxyhydroxide; Peritoneal dialysis -- Periodicals; Continuous ambulatory peritoneal dialysis -- Periodicals; 617.461059
• DOI: 10.1177/0896860820915019
• Languages: English
• ISSNs: 0896-8608

Abstract

A 49-year-old woman developed eosinophilic peritonitis 2 months after starting continuous ambulatory peritoneal dialysis because of congenital right kidney hypoplasia and chronic glomerulonephritis. This was shown to have been induced by sucroferric oxyhydroxide, an iron-based phosphate binder, using a drug-induced lymphocyte stimulation test. Her eosinophilic peritonitis was improved after stopping the administration of sucroferric oxyhydroxide without providing any immunosuppressive agents.